State of Alaska Department of Revenue’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.68M | Sell |
17,031
-476
| -3% | -$91.1K | 0.04% | 422 |
|
|
2026
Q1 | $3.21M | Buy |
17,507
+320
| +2% | +$59K | 0.03% | 483 |
|
|
2025
Q4 | $3.02M | Sell |
17,187
-995
| -5% | -$163K | 0.03% | 502 |
|
|
2025
Q3 | $2.55M | Sell |
18,182
-877
| -5% | -$119K | 0.03% | 610 |
|
|
2025
Q2 | $2.39M | Sell |
19,059
-660
| -3% | -$82.2K | 0.03% | 627 |
|
|
2025
Q1 | $2.7M | Buy |
19,719
+540
| +3% | +$77.2K | 0.03% | 536 |
|
|
2024
Q4 | $2.93M | Sell |
19,179
-5,691
| -23% | -$960K | 0.03% | 509 |
|
|
2024
Q3 | $4.82M | Sell |
24,870
-4,900
| -16% | -$1.03M | 0.05% | 369 |
|
|
2024
Q2 | $6.9M | Sell |
29,770
-3,870
| -12% | -$841K | 0.08% | 252 |
|
|
2024
Q1 | $7.25M | Sell |
33,640
-4,910
| -13% | -$1.15M | 0.08% | 245 |
|
|
2023
Q4 | $9.97M | Sell |
38,550
-8,625
| -18% | -$2.12M | 0.12% | 178 |
|
|
2023
Q3 | $12.1M | Sell |
47,175
-565
| -1% | -$151K | 0.15% | 130 |
|
|
2023
Q2 | $13.6M | Sell |
47,740
-924
| -2% | -$275K | 0.16% | 117 |
|
|
2023
Q1 | $13.5M | Buy |
48,664
+243
| +0.5% | +$67.2K | 0.16% | 127 |
|
|
2022
Q4 | $13.4M | Buy |
48,421
+842
| +2% | +$238K | 0.17% | 125 |
|
|
2022
Q3 | $12.7M | Sell |
47,579
-2,181
| -4% | -$463K | 0.17% | 114 |
|
|
2022
Q2 | $10.1M | Sell |
49,760
-4,235
| -8% | -$866K | 0.12% | 179 |
|
|
2022
Q1 | $11.4M | Sell |
53,995
-3,840
| -7% | -$835K | 0.12% | 172 |
|
|
2021
Q4 | $13.9M | Sell |
57,835
-8,085
| -12% | -$2.08M | 0.13% | 158 |
|
|
2021
Q3 | $18.7M | Sell |
65,920
-3,614
| -5% | -$1.18M | 0.19% | 111 |
|
|
2021
Q2 | $24.1M | Buy |
69,534
+9,568
| +16% | +$2.9M | 0.24% | 76 |
|
|
2021
Q1 | $16.8M | Sell |
59,966
-4,698
| -7% | -$1.27M | 0.18% | 117 |
|
|
2020
Q4 | $15.8M | Sell |
64,664
-26,282
| -29% | -$6.78M | 0.18% | 119 |
|
|
2020
Q3 | $25.8M | Buy |
90,946
+31,930
| +54% | +$8.91M | 0.32% | 64 |
|
|
2020
Q2 | $15.8M | Buy |
59,016
+26,687
| +83% | +$8.02M | 0.2% | 97 |
|
|
2020
Q1 | $10.2M | Buy |
32,329
+1,647
| +5% | +$500K | 0.16% | 161 |
|
|
2019
Q4 | $9.1M | Sell |
30,682
-3,080
| -9% | -$855K | 0.12% | 243 |
|
|
2019
Q3 | $7.86M | Buy |
33,762
+4,633
| +16% | +$1.08M | 0.11% | 278 |
|
|
2019
Q2 | $6.81M | Sell |
29,129
-872
| -3% | -$201K | 0.11% | 205 |
|
|
2019
Q1 | $7.09M | Sell |
30,001
-1,185
| -4% | -$373K | 0.13% | 189 |
|
|
2018
Q4 | $9.38M | Buy |
31,186
+192
| +0.6% | +$61.3K | 0.18% | 125 |
|
|
2018
Q3 | $10.9M | Sell |
30,994
-1,464
| -5% | -$504K | 0.18% | 129 |
|
|
2018
Q2 | $9.42M | Buy |
32,458
+6,100
| +23% | +$1.71M | 0.17% | 140 |
|
|
2018
Q1 | $7.21M | Buy |
26,358
+4,110
| +18% | +$1.28M | 0.15% | 154 |
|
|
2017
Q4 | $7.09M | Buy |
22,248
+20,408
| +1,109% | +$6.55M | 0.17% | 138 |
|
|
2017
Q3 | $576K | Buy |
+1,840
| New | +$545K | 0.03% | 656 |
|
Other funds holding BIIB
State of Alaska Department of Revenue's BIIB Position: Q2 2026 in Review
State of Alaska Department of Revenue reduced its Biogen (BIIB) stake by 2.7% in Q2 2026, selling an estimated $91.1K and leaving 17,031 shares worth $3.68M. The position accounts for 0.04% of the portfolio, ranked #422.
State of Alaska Department of Revenue first reported a position in BIIB in Q3 2017 and has held it in 36 quarters since. The position peaked at $25.8M in Q3 2020. 750 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- State of Alaska Department of Revenue held 17,031 shares of Biogen worth $3.68M as of Q2 2026.
- State of Alaska Department of Revenue sold 476 Biogen shares in Q2 2026, an estimated $91.1K.
- Biogen made up 0.04% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #422 holding.
- State of Alaska Department of Revenue first reported a position in Biogen in Q3 2017 and has held it in 36 quarters since.
- State of Alaska Department of Revenue's Biogen position peaked at $25.8M in Q3 2020.
- 750 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.